Research Progress of The Effective Ingredients of Radix Salviae Miltiorrhizae, Tanshinone IIA and Salvianolic Acid A

Abstract

Abstract: Many studies have showed that Radix Salviae Miltiorrhizae(RSM)，with multi-ingredients, has effects of antioxidant, anti-clotting and antitumor. Currently, the studies on RSM monomers have been more in-depth. Using modern biology approaches, increasing reports are concerning the mechanism and the targets of these ingredients. RSM active ingredients are mainly divided into fat-soluble tanshinones and water-soluble dan phenolic acids. Recent pharmacological findings of tanshinone II A (fat-soluble) and Salvianolic acid A (water-soluble) were reviewed.

Key words: radix salviae miltiorrhizae, tanshinone II A, salvianolic acid A

CLC Number:

R285，R961

JIN Can, ZHANG Dan-shen. Research Progress of The Effective Ingredients of Radix Salviae Miltiorrhizae, Tanshinone IIA and Salvianolic Acid A[J]. ACTA NEUROPHARMACOLOGICA, 2012, 2(4): 58-64.

References

[1] 卫生部药典委员会. 中华人民共和国药典（一部）[S]. 北京，人民卫生出版社, 2005: 52-53.

[2] 杜冠华, 张均田. 丹参水溶性有效成分-丹酚酸研究进展[J]. 基础医学与临床, 2000, 20(5): 394-398.

[3] 刘梅, 夏鑫华, 张志敏, 等. 丹参素、原儿茶醛、咖啡酸和丹酚酸B体外抗氧化活性比较研究[J]. 中药材, 2009, 32(2): 265-267.

[4] 张萌涛, 钱亦华, 唐安琪, 等. 丹参酮II A药理作用的研究进展[J]. 医学综述, 2010, 16(17): 2661-2664.

[5] 甘发平. 丹参酮II A的药动学研究及透过血脑屏障的初步考察[D]. 杭州, 浙江大学药学院, 2008, 39-50.

[6] 王炎, 冯年平, 南艺蕾, 等. 丹参酮II A聚乳酸载药纳米粒体内药物分布初步研究[J]. 中药材, 2011, 32(9): 1392-1395.

[7] Liu Xin, Ye Ming, An Chi-ying, et al. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia[J]. Biomaterials, 2013, 34(28): 6893-6905.

[8] Tzu Yu Lin, Lu Cheng-wei, Shu-Kuei Huang, et al. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals [J]. J Ethnopharmacol, 2013, 147(2): 488-496.

[9] 何治, 潘志红, 鲁文红. 丹参酮II A对局灶性脑缺血大鼠的神经保护作用及其机制初探[J]. 中药药理与临床, 2009, 25(5): 32-33.

[10] 何治, 潘志红, 鲁文红. 丹参酮II A对血管性痴呆大鼠的神经保护作用机制[J]. 中国中药杂志, 2010, 35(14): 1883-1886.

[11] 黑明燕, 刘芙蓉, 罗娅丽. 丹参酮II A对新生大鼠缺氧缺血性脑损伤磷酸化NMDA受体 1 表达及细胞内游离钙离子浓度的影响[J]. 中南大学学报（医学版), 2010, 35(9): 940-946.

[12] 陈卫银, 孙承铭, 王会民, 等. 丹参酮II A预处理对局灶性脑缺血再灌注损伤大鼠神经细胞保护作用及GFAP表达的影响[J]. 山东医药, 2011, 51(8): 35-37.

[13] 李浩, 刘开祥, 俸军林. 丹参酮II A对鼠脑缺血再灌注损伤MPC-1和IL-1β含量的影响[J]. 中国中医急症, 2008, 17(7): 957-975.

[14] 李浩, 刘开祥, 俸军林. 丹参酮II A对鼠脑缺血再灌注损伤MPC-1和TNF-α含量的影响[J]. 中华中医药学刊, 2009, 27(1): 160-162.

[15] 李浩, 刘开祥, 俸军林. 丹参酮II A对鼠脑缺血再灌注损伤一氧化氮及一氧化氮合酶的影响[J]. 中国康复理论与实践, 2008, 14(5): 430-432.

[16] 张浩, 任国庆. 内皮祖细胞与冠状动脉粥样硬化关系的研究进展[J]. 实用医学杂志, 2009, 25(5): 814-816.

[17] 王娟, 都鹏飞. 丹参酮II A及烟酸对肥胖幼鼠心血管功能的影响[J]. 实用医学杂志, 2011, 27(18): 3293-3295.

[18] Paul Chan, Liu I-Min, Li Ying-xiao, et al. Antihypertension induced by Tanshinone II A isolated from the roots of Salvia miltiorrhiza [J]. Evid Based Complement Alternat Med, 2011, 2011: 1-8.

[19] 祖晓麟, 郭焕伟, 王晓舟, 等. 丹参酮II A-磺酸钠注射液对心脏X综合征患者炎症因子和血管内皮功能的影响[J]. 中国医药导刊, 2012, 14(8): 1388-1389.

[20] 刘纯, 许赤多, 贾秀琴. 丹参酮II A对佐剂型关节炎大鼠离体胸主动脉环的舒张作用及对外周vWF表达的影响[J]. 深圳中西医结合杂志, 2009, 19(2): 77-80.

[21] Yuan Shu-lan, Huang Ren-min, Wang Xiu-jie, et al. Reversing effect of tanshinone on malignant phenotypes of human hepatocarcinoma cell line[J]. World J Gastroenterol, 1998, 4(4): 317-319.

[22] 刘志刚, 羊裔明, 孟文彤, 等. 丹参酮II A与全反式维甲酸协同诱导急性早幼粒细胞白血病细胞株的分化和凋亡[J]. 四川大学学报(医学版), 2004, 35(6): 788-791.

[23] Yun Sun-mi, Ji Hoon Jung, Soo-Jin Jeong, et al. Tanshinon IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6k in KBM-5 leukemia cells[J]. Phytother Res, 2013, Doi: 10. 1002/ptr. 5015.

[24] Shang Yun-feng, Shen Xian, Xie Yuan-kang, et al. Inhibitory effects of Tanshinone II A on invasion and metastasis of human colon carcinoma cells[J]. Acta Pharm Sin, 2009, 30(11): 1537-1542.

[25] 赵丕文, 牛建昭, 王继峰, 等. 丹参酮II A抗乳腺癌细胞增殖作用研究[J]. 中国药理学通报, 2010, 26(7): 903-906.

[26] 王炎, 李琦, 范忠泽, 等. 丹参酮II A介导p38MAPK信号转导诱导人肝癌细胞凋亡[J]. 世界华人消化杂志, 2009, 17(2): 124-129.

[27] Xin Yin, Yue Yin, Cao Fa-le, et al. Tanshinone II a attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats[J]. PLoS One, 2012, 7(6): 38381-38390.

[28] 张莉, 张维库, 赵莹, 等. 丹酚酸A的研究与进展[J]. 中国中药杂志, 2011, 36(19): 2603-2609.

[29] Pei Li-xia, Bao Yuan-wu, Wang Hai-di, et al. A sensitive method for determination of salvianolic acid A in rat plasma using liquid chromatography/tandem mass spectrometry[J]. Biomed Chromatogr, 2008, 22(7): 786-794.

[30] Guo H F, Zou X L, Xu H, et al. Effects of salvianolic A on rat liver microsomal cytochrome P450 system [J]. Zhong guo Zhong Yao Za Zhi, 2010, 35(3): 348-351.

[31] 林力, 刘建勋, 张颖, 等. LC-MS/MS 法同时测定犬血浆中丹酚酸 A、丹酚酸 B、紫草酸和迷迭香酸及其在丹参提取物的药代动力学研究应用[J]. 世界科学技术-中医药现代化, 2012, 14(3): 1567-1571.

[32] 杨秀颖, 强桂芬, 张莉, 等. 丹酚酸A对缺血/再灌注心肌的保护作用研究[J]. 中国药理学通报, 2011, 27(8): 1072-1076.

[33] 林治荣, 陈程, 田登科, 等. 丹酚酸A与丹酚酸B抗大鼠心肌缺血再灌注损伤的比较研究[J]. 时珍国医国药, 2011, 22(2): 412-414.

[34] Wang Shou-bao, Pang Xiao-bin, Zhao Yan, et al. Protection of salvianolic acid a on rat brain from ischemic damage via soluble epoxide hydrolase inhibition [J]. J Asian Nat Prod Res, 2012, 14(11): 1084-1092.

[35] 姜民, 郭利平, 李晶, 等. 丹酚酸A对局灶性脑缺血再灌注损伤大鼠CD11b/CD18表达的影响[J]. 辽宁中医杂志, 2008, 35(9): 1425-1426.

[36] Wang Bao, Liu Jian-xun, Meng Hong-xu, et al. Blocking effect of salvianolic acid A on calcium channels in isolated rat ventricular myocytes[J]. Chin J Integr Med, 2012, 18(5): 366-370.

[37] 姜民, 郭利平, 周王怡, 等. 丹酚酸A对缺氧/复氧损伤条件下脑微血管内皮细胞ICAM-1表达的影响[J]. 天津中医药, 2008, 25(5): 406-407.

[38] Yao Jun, Mu Yang-ling, Fred H Gage. Neural stem cells: mechanisms and modeling[J]. Protein Cell, 2012, 3(4): 251-261.

[39] Cao Ying-ying, Wang Ling, Ge Hu, et al. Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer`s disease[J]. Mol Divers, 2013, 17(3): 515-524.

[40] 黄张森. 丹酚酸A通过抑制3羧基磷脂酰肌醇激酶（PI3K）途径降低血小板激活和动脉血栓形成[D]. 杭州, 浙江大学医学院, 2011: 17-30.

[41] 范华英. 丹酚酸A抗血小板及抗血栓作用的研究[D]. 长春, 吉林大学生命科学学院, 2012: 29-35.

[42] Lin Yun-lian, Lee Ting-fang, Yeh-Jeng Huang, et al. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells[J]. J Pharmacol, 2006, 58(7): 933-939.

[43] Wang Chao-yun, Ma Fu-lu, Liu Jun-tian, et al. Protective effect of salvianic acid a on acute liver injury induced by carbon tetrachloride in rats[J]. Biol Pharm Bull, 2007, 30(1): 44-47.

[44] Wu Zhi-ming, Wen Tao, Tan Yu-fen, et al. Effects of salvianolic acid a on oxidative stress and liver injury induced by carbon tetrachloride in rats[J]. Basic Clin Pharmacol Toxicol, 2007, 100(2): 115-120.

[45] Ming Kuei Tsai, Lin Yun-lian, Yi-Tsau Huang. Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats[J]. Toxicol Appl Pharmacol, 2010, 242(2): 155-164.

[46] Ming Kuei Tsai, Lin Yun-lian, Yi-Tsau Huang. Differential inhibitory effects of salvianolic acid on activation of rat hepatic stellate cells by platelet-derived growth factor[J]. Planta Med, 2011, 77(13): 1497-1503.

[47] 方莲花, 王月华, 何国荣, 等. 丹酚酸A对实验性糖尿病大鼠的降糖作用及其机制初探[J]. 中国新药杂志, 2011, 20(21): 2063-2068.

[48] Yu Xiao-yan, Zhang Li, Yang Xiu-ying, et al. Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1α-Sirt3 axis[J]. Molecules, 2012, 17(9): 11216-11228.

[49] 甄永苏. 天然来源的新型抗肿瘤生化调节剂[J]. 中国肿瘤, 1999, 8(10): 459-460.

[50] Liu Xiu, Yang Yan, Zhang Xiao-xiang, et al. Compound astragalus and salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell[J]. J Gastroenterol Hepatol, 2010, 25(2): 420-426.

[51] Li Hong-yan, Li Yan, Yan Chun-hong, et al. Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A[J]. J Asian Nat Prod Res, 2002, 4(4): 271-280.

[52] 姜静宜, 单悦梅, 高明奇, 等. 丹酚酸A 对缺血再灌注大鼠缺血期胃粘膜血流量及再灌注期胃粘膜脂质过氧化的影响[J]. 微循环, 2008, 18(2): 25-27.

[53] Cui Liao, Liu Yu-yu, Wu Tie, et al. Osteogenic effects of D(+)β-3,4-dihydroxyphenyl lactic acid（salvianic acid A, SAA）on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats[J]. Acta Pharmacol Sin, 2009, 30(3): 321-332.